Decision Aid Summary

Title The BRCA1/2 gene mutation test to evaluate the risks of breast and ovarian cancer ; Le dépistage des mutations génétiques BRCA1/2 pour évaluer les risques de cancer du sein et de l'ovaire
Audience Clinicians presenting information about the BRCA1/2 test to patients.
Options included Taking the BRCA1/2 test.
Not taking the BRCA1/2 test.
Year of last update or review 2011
Format Web, paper, PDF
How to obtain Click here to view the decision aid on the developer website
Developer Anik Giguère
Where was it developed?
Université Laval
Health condition Breast and Ovarian Cancer
Type of decision aid Screening
Language English, French
Based on IPDAS criteria (International Patient Decision Aid Standards) this decision aid (and/or supporting materials) meets:
6 out of 7 criteria to be defined as a patient decision aid
7 out of 9 criteria to lower the risk of making a biased decision
1 out of 4 other criteria for decision aids about screening or testing

Last modified: 2017-04-06.